420 related articles for article (PubMed ID: 27334585)
21. Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model.
Schleiss MR; Anderson JL; McGregor A
Virol J; 2006 Mar; 3():9. PubMed ID: 16509982
[TBL] [Abstract][Full Text] [Related]
22. An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.
Leviton MP; Lacayo JC; Choi KY; Hernandez-Alvarado N; Wey A; Schleiss MR
Clin Dev Immunol; 2013; 2013():906948. PubMed ID: 24000289
[TBL] [Abstract][Full Text] [Related]
23. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
[TBL] [Abstract][Full Text] [Related]
24. Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.
Choi KY; El-Hamdi NS; McGregor A
J Gen Virol; 2020 Apr; 101(4):426-439. PubMed ID: 32068527
[TBL] [Abstract][Full Text] [Related]
25. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection.
Schleiss MR; Lacayo JC; Belkaid Y; McGregor A; Stroup G; Rayner J; Alterson K; Chulay JD; Smith JF
J Infect Dis; 2007 Mar; 195(6):789-98. PubMed ID: 17299708
[TBL] [Abstract][Full Text] [Related]
26. Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta.
Hashimoto K; Yamada S; Katano H; Fukuchi S; Sato Y; Kato M; Yamaguchi T; Moriishi K; Inoue N
Vaccine; 2013 Jun; 31(31):3199-205. PubMed ID: 23684839
[TBL] [Abstract][Full Text] [Related]
27. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.
Schleiss MR
J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834
[TBL] [Abstract][Full Text] [Related]
28. Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain Variant.
Fernández-Alarcón C; Buchholz G; Contreras H; Wussow F; Nguyen J; Diamond DJ; Schleiss MR
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960820
[TBL] [Abstract][Full Text] [Related]
29. MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission.
Contreras H; Wussow F; Fernández-Alarcón C; Bierle C; Nguyen J; Diamond DJ; Schleiss MR
Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31739399
[TBL] [Abstract][Full Text] [Related]
30. Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.
Loomis RJ; Lilja AE; Monroe J; Balabanis KA; Brito LA; Palladino G; Franti M; Mandl CW; Barnett SW; Mason PW
Vaccine; 2013 Jan; 31(6):919-26. PubMed ID: 23246547
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.
Schleiss MR; Bourne N; Jensen NJ; Bravo F; Bernstein DI
Viral Immunol; 2000; 13(2):155-67. PubMed ID: 10892996
[TBL] [Abstract][Full Text] [Related]
32. Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).
McGregor A; Liu F; Schleiss MR
J Virol; 2004 Sep; 78(18):9872-89. PubMed ID: 15331722
[TBL] [Abstract][Full Text] [Related]
33. A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
McVoy MA; Lee R; Saccoccio FM; Hartikka J; Smith LR; Mahajan R; Wang JB; Cui X; Adler SP
Vaccine; 2015 Dec; 33(51):7328-7336. PubMed ID: 26597035
[TBL] [Abstract][Full Text] [Related]
34. A Homolog Pentameric Complex Dictates Viral Epithelial Tropism, Pathogenicity and Congenital Infection Rate in Guinea Pig Cytomegalovirus.
Coleman S; Choi KY; Root M; McGregor A
PLoS Pathog; 2016 Jul; 12(7):e1005755. PubMed ID: 27387220
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus vaccines.
McVoy MA
Clin Infect Dis; 2013 Dec; 57 Suppl 4(Suppl 4):S196-9. PubMed ID: 24257427
[TBL] [Abstract][Full Text] [Related]
36. Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus.
Dasari V; Smith C; Zhong J; Scott G; Rawlinson W; Khanna R
J Gen Virol; 2011 May; 92(Pt 5):1021-1031. PubMed ID: 21307228
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.
Bernstein DI; Munoz FM; Callahan ST; Rupp R; Wootton SH; Edwards KM; Turley CB; Stanberry LR; Patel SM; Mcneal MM; Pichon S; Amegashie C; Bellamy AR
Vaccine; 2016 Jan; 34(3):313-9. PubMed ID: 26657184
[TBL] [Abstract][Full Text] [Related]
38. Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection.
Schleiss MR; Bourne N; Bravo FJ; Jensen NJ; Bernstein DI
J Virol Methods; 2003 Mar; 108(1):103-10. PubMed ID: 12565160
[TBL] [Abstract][Full Text] [Related]
39. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
[TBL] [Abstract][Full Text] [Related]
40. Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects.
Adler SP; Lewis N; Conlon A; Christiansen MP; Al-Ibrahim M; Rupp R; Fu TM; Bautista O; Tang H; Wang D; Fisher A; Culp T; Das R; Beck K; Tamms G; Musey L;
J Infect Dis; 2019 Jul; 220(3):411-419. PubMed ID: 31535143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
